Illinois Hospital Report Card

and Consumer Guide to Health Care

UChicago Medicine AdventHealth Bolingbrook

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
154	Complete Reporting: Number of predicted events too low to calculate a precise SIR

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 1 infections, 24281 patient days Rating SIR: N/A	1 infections, 24281 patient days	N/A
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 25133 patient days ¹⁵⁴ Rating SIR: N/A ¹⁵⁴	2 infections, 25133 patient days ¹⁵⁴	N/A ¹⁵⁴
Q1 2021 - Q4 2021 Result 3 infections, 24759 patient days ¹⁵⁴ Rating SIR: N/A ¹⁵⁴	3 infections, 24759 patient days ¹⁵⁴	N/A ¹⁵⁴
Q1 2020 - Q4 2020 Result 0 infections, 24174 patient days ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 24174 patient days ¹¹⁸	N/A ¹¹⁸
Q1 2019 - Q4 2019 Result 1 infections, 24930 patient days ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 24930 patient days ⁴⁷	N/A ⁴⁷
Q1 2018 - Q4 2018 Result 0 infections, 26489 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 26489 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 26679 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 26679 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 1 infections, 25748 patient days Rating SIR: 0.78	1 infections, 25748 patient days	0.78
Q1 2015 - Q4 2015 Result 1 infections, 22091 patient days Rating SIR: 0.97	1 infections, 22091 patient days	0.97
Q1 2014 - Q4 2014 Result 0 infections, 20561 patient days ⁴⁵ Rating SIR: N/A ⁴⁵	0 infections, 20561 patient days ⁴⁵	N/A ⁴⁵
Q1 2013 - Q4 2013 Result 0 infections, 21560 patient days ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 21560 patient days ¹¹⁸	N/A ¹¹⁸
Q1 2012 - Q4 2012 Result 0 infections, 21309 patient days ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 21309 patient days ¹¹⁸	N/A ¹¹⁸
Q1 2012 - Q2 2012 Result 0 infections, 10416 patient days Rating SIR: 0.00	0 infections, 10416 patient days	0.00
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 1 infections, 22101 patient days Rating SIR: 0.12	1 infections, 22101 patient days	0.12
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 4 infections, 23264 patient days Rating SIR: 0.34	4 infections, 23264 patient days	0.34
Q1 2021 - Q4 2021 Result 4 infections, 22930 patient days Rating SIR: 0.33	4 infections, 22930 patient days	0.33
Q1 2020 - Q4 2020 Result 7 infections, 22238 patient days Rating SIR: 0.58	7 infections, 22238 patient days	0.58
Q1 2019 - Q4 2019 Result 7 infections, 22471 patient days Rating SIR: 0.58	7 infections, 22471 patient days	0.58
Q1 2018 - Q4 2018 Result 9 infections, 23617 patient days Rating SIR: 0.64	9 infections, 23617 patient days	0.64
Q1 2017 - Q4 2017 Result 14 infections, 23916 patient days Rating SIR: 0.85	14 infections, 23916 patient days	0.85
Q1 2016 - Q4 2016 Result 9 infections, 23000 patient days Rating SIR: 0.40	9 infections, 23000 patient days	0.40
Q1 2015 - Q4 2015 Result 18 infections, 20253 patient days Rating SIR: 1.14	18 infections, 20253 patient days	1.14
Q1 2014 - Q4 2014 Result 10 infections, 18086 patient days Rating SIR: 0.68	10 infections, 18086 patient days	0.68
Q1 2013 - Q4 2013 Result 18 infections, 19022 patient days Rating SIR: 1.16	18 infections, 19022 patient days	1.16
Q1 2012 - Q4 2012 Result 15 infections, 18563 patient days Rating SIR: 0.99	15 infections, 18563 patient days	0.99